Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats

Pharmacological Research

Volumn 51, Issue 4, 2005, Pages 359-365

  Mougenot, Nathalie ^a   Médiani, Odile ^a   Lechat, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Bisoprolol; Cardiovascular remodeling; Endothelium; Hydrochlorothiazide; Spontaneously hypertensive rats

Indexed keywords

BISOPROLOL; HYDROCHLOROTHIAZIDE; NEUROHORMONE; RENIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; ENDOTHELIUM; ENZYME ACTIVATION; HEART RATE; HEART VENTRICLE HYPERTROPHY; HORMONAL REGULATION; HYPERTENSION; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 15944369997     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2004.10.010     Document Type: Article

References (42)

1. A. Dang, D. Zheng, B. Wang, Y. Zhang, P. Zhang, and M. Xu The role of the rennin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats Hypertens Res 22 1999 217 221
2. M. Esler Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases J Cardiovasc Pharmacol 26 Suppl 2 1995 S24 S28
3. G. Noll, R.R. Wenzel, C. Binggeli, C. Corti, and T.F. Lusher Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs Eur Heart J 19 Suppl F 1998 32 38
4. K.H. Rahn, M. Barenbrock, and M. Hausberg The sympathetic nervous system in the pathogenesis of hypertension J Hypertens 17 Suppl 3 1999 S11 S14
5. F. Rabbia, G. Martini, G. Cat Genova, A. Milan, L. Chiandussi, and F. Veglio Antihypertensive drugs and sympathetic nervous system Clin Exp Hypertens 23 2001 101 111
6. R.R. Wenzel, H. Bruck, G. Noll, R.F. Schäfers, A.E. Daul, and T. Philipp Antihypertensive drugs and sympathetic nervous system J Cardiovasc Pharmacol 35 Suppl 4 2000 43 52
7. E. Agabiti-Rosei, M.L. Muiesan, A. Geri, G. Romanelli, M. Beschi, and M. Castelleno Long-term antihypertensive treatment may induce normalization of left ventricular mass before complete regression of vascular structural changes: consequences for cardiac function at rest and during stress J Hypertens 6 Suppl 4 1988 94 96
8. J.B. Park, H.D. Intengan, and E.L. Schiffrin Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension J Renin Angiotensin Aldosterone Syst 1 2000 40 45
9. M. Schartl, W.G. Bocksch, S. Dreysse, S. Beckmann, O. Franke, and U. Hunten Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients J Hypertens 12 1994 S37 S42
10. F. Charocopos The mechanism of beta-adrenergic receptor blockade-induce elevation of arterial blood pressure in rats Arch Int Physiol Biochim 90 1982 173 178
11. J. Champlain, M. Karas, C. Toal, R. Nadeau, and P. Larochelle Effects of antihypertensive therapies on the sympathetic nervous system Can J Cardiol 15 Suppl A 1999 8A 14A
12. F.H. Messerli, and K. Chander Cardiac effects of combination therapy in hypertension J Cardiovasc Pharmacol 35 3 2000 S17 S22
13. A.H. Gradman, and C. Acevedo Evolving strategies for the use of combination therapy in hypertension Curr Hypertens Rep 4 2002 343 349
14. R.C. Gupta, and G.L. Bhan Treatment of elderly hypertensives with beta-blocker/thiazide combination Compr Gerontol 1 1987 112 114
15. D.D. Sisson, G.B. Daniel, and A.R. Twardock Comparison of left ventricular ejection fractions determined healthy anesthetized dogs by echocardiography and gated equilibrium radionuclide ventriculography Am J Vet Res 50 1989 1840 1847
16. C.D. Kilts, G.R. Breese, and R.B. Mailman Simultaneous quantification of dopamine, hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection J Chromatogr 225 1981 347 357
17. F.H. Schaison, J.F. Ramirez-Gil, S. Ciferri, M. Bernard, B. Baudin, and N. Mougenot Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats J Cardiovasc Pharmacol 28 1996 11 18
18. N. Mougenot, P. Lesnik, J.F. Ramirez-Gil, P. Nataf, U. Diczfalusy, and M.J. Chapman Effect of the oxydation state of LDL on the modulation of arterial vasomotor response in vitro Atherosclerosis 133 1997 183 192
19. W.H. Frishman, B.S. Bryzinski, L.R. Coulsob, V.L. DeQuattro, N.D. Vlachakis, and W.J. Mroczeck A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide Arch Intern Med 154 13 1994 1461 1468
20. A. Robert, N. Thorin-trescases, L. Oster, C. Capteville-Atkinson, and J. Atkinson Myoplasmic calcium-vasoconstriction coupling in the perfused caudal artery of adult spontaneously hypertensive rats. Effect of antihypertensive treatment Therapie 48 1993 345 349
21. T. Wada, T. Sanada, M. Ojima, R. Kanagawa, K. Nishikawa, and Y. Inada Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats Hypertens Res 19 1996 247 254
22. W. Koenig, L. Binner, F. Gabrielsen, M. Sund, J. Rosenthal, and V. Hombach Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension J Cardiovasc Pharmacol 18 1991 349 353
23. J.D. Blumenfeld, J.E. Sealey, S.J. Mann, A. Bragat, R. Marion, and M.S. Pecker β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in Normotensive and hypertensive subjects Am J Hypertens 12 1999 451 459
24. P. Chamiot-Clerc, J.F. Renaud, and M.E. Safar Pulse pressure, aortic reactivity, and endothelium dysfunction in old hypertensive rats Hypertension 37 2001 313 321
25. G.S. Wang, Y.S. Li, and S.X. Fu Effects of hydrochlorothiazide on contraction and 86Rb efflux in aorta Zhongguo Yao Li Xue Bao 14 1993 409 413
26. J.A. Calder, M. Schachter, and P.S. Sever Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds J Pharmacol Exp Ther 265 1993 1175 1180
27. 2+]I by hydrochlorothiazide in guinea-pig isolated mesenteric arteries Br J Pharmacol 114 1995 703 707
28. J.A. Calder, M. Schachter, and P.S. Sever Direct vascular actions of hydrochlorothiazide and indapamide in isolated small vessels Eur J Pharmacol 220 1992 19 26
29. J. Conway, and H. Palmero The vascular effects of thiazide diuretics Arch Intern Med 111 1963 203 207
30. P. Giummelly, I. Lartaud-Idjouadiene, V. Marque, N. Niederhoffer, J.M. Chillon, and C. Capteville-Atkinson Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats Hypertension 34 1999 207 211
31. M. Safar, P. Chamiot-Clerc, G. Dagher, and J.F. Renaud Pulse pressure, endothelium function, and arterial stiffness in spontaneously hypertensive rats Hypertension 38 2001 1416 1421
32. F.H. Saleh, and A.R. Jurjus A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with angiotensin-converting enzyme inhibitor or a calcium-channel blocker J Pathol 193 2001 415 420
33. H.D. Intengan, and E.L. Schiffrin Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats Hypertension 35 2000 1221 1225
34. G.F. Mitchell, J.L. Izzo, Y. Lacourcière, J.P. Ouellet, J. Neutel, and C. Qian Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension Circulation 105 2002 2955 2961
35. E. Millette, B. Demeilliers, R. Wu, M.A. Laplante, A. El Midaoui, and P. Moreau Comparison of cardiovascular protection by omapatrilat and lisinopril treatments in Doca-salt hypertension J Hypertens 21 2003 125 135
36. J.M. Ledingham, E.L. Phelan, M.A. Cross, and R. Laverty Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine J Vasc Res 37 2000 134 145
37. A. Benetos, P. Poitevin, P.L. Prost, M.E. Safar, and B.I. Levy Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats Am J Hypertens 7 1994 186 192
38. J.Z. Su, S.C. Chen, K.G. Wu, D.G. Chen, H.B. Rui, and X.Y. Wang Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats Zhongguo Yao Li Xue Bao 20 1999 923 928
39. M.F. Neves, A. Virdis, and E.L. Schiffrin Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism J Hypertens 21 2003 189 198
40. T. Hasegawa, S. Takagi, K. Nishimaki, K. Morita, and S. Nakajima Impairment of l-arginine metabolism in spontaneously hypertensive rats Biochem Int 26 1992 653 658
41. C.F. Küng, and T.F. Lüscher Different Mechanisms of endothelial dysfunction with aging and hypertension in rat aorta Hypertension 25 1995 194 200
42. M.J. Crespo, and W.C. De Mello Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamster Eur J Pharmacol 420 2001 133 141